IT1201436B - Formulazioni topiche a lento rilascio - Google Patents

Formulazioni topiche a lento rilascio

Info

Publication number
IT1201436B
IT1201436B IT21654/85A IT2165485A IT1201436B IT 1201436 B IT1201436 B IT 1201436B IT 21654/85 A IT21654/85 A IT 21654/85A IT 2165485 A IT2165485 A IT 2165485A IT 1201436 B IT1201436 B IT 1201436B
Authority
IT
Italy
Prior art keywords
slow release
release formulations
salts
topical
topical slow
Prior art date
Application number
IT21654/85A
Other languages
English (en)
Other versions
IT8521654A0 (it
Inventor
Vincenzo Zappia
Rosa Mario De
Original Assignee
Vincenzo Zappia
Rosa Mario De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vincenzo Zappia, Rosa Mario De filed Critical Vincenzo Zappia
Priority to IT21654/85A priority Critical patent/IT1201436B/it
Publication of IT8521654A0 publication Critical patent/IT8521654A0/it
Priority to DE198686109454T priority patent/DE211268T1/de
Priority to AT86109454T priority patent/ATE67488T1/de
Priority to EP86109454A priority patent/EP0211268B1/en
Priority to DE8686109454T priority patent/DE3681529D1/de
Priority to JP61170714A priority patent/JPS6236367A/ja
Application granted granted Critical
Publication of IT1201436B publication Critical patent/IT1201436B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT21654/85A 1985-07-19 1985-07-19 Formulazioni topiche a lento rilascio IT1201436B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT21654/85A IT1201436B (it) 1985-07-19 1985-07-19 Formulazioni topiche a lento rilascio
DE198686109454T DE211268T1 (de) 1985-07-19 1986-07-10 Topische praeparate mit verzoegerter freigabe.
AT86109454T ATE67488T1 (de) 1985-07-19 1986-07-10 Topische praeparate mit verzoegerter freigabe.
EP86109454A EP0211268B1 (en) 1985-07-19 1986-07-10 Slow-release topical formulations
DE8686109454T DE3681529D1 (de) 1985-07-19 1986-07-10 Topische praeparate mit verzoegerter freigabe.
JP61170714A JPS6236367A (ja) 1985-07-19 1986-07-18 ミノキシジル塩、その製法およびそれを有効成分とする外用剤または化粧料

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21654/85A IT1201436B (it) 1985-07-19 1985-07-19 Formulazioni topiche a lento rilascio

Publications (2)

Publication Number Publication Date
IT8521654A0 IT8521654A0 (it) 1985-07-19
IT1201436B true IT1201436B (it) 1989-02-02

Family

ID=11184897

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21654/85A IT1201436B (it) 1985-07-19 1985-07-19 Formulazioni topiche a lento rilascio

Country Status (5)

Country Link
EP (1) EP0211268B1 (it)
JP (1) JPS6236367A (it)
AT (1) ATE67488T1 (it)
DE (2) DE3681529D1 (it)
IT (1) IT1201436B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86547A1 (fr) * 1986-08-07 1988-03-02 Oreal Suspension pour induire et stimuler la croissance des cheveux et diminuer leur chute a base de derives de la pyrimidine
US4828837A (en) * 1987-03-30 1989-05-09 Liposome Technology, Inc. Non-crystalline minoxidil composition, its production and application
JPS63186560A (ja) * 1987-05-15 1988-08-02 Toshiba Corp 電圧共振形高周波スイッチング回路
LU86958A1 (fr) * 1987-07-31 1989-03-08 Oreal Sels d'acide thiamorpholinone carboxylique et de derives de diamino-2,4 pyrimidine,leur utilisation en cosmetique et pharmacie
EP0330453A1 (en) * 1988-02-26 1989-08-30 Minnesota Mining And Manufacturing Company Scalp treatment composition
DE3816995A1 (de) * 1988-05-19 1989-11-23 Hoechst Ag Verwendung von pyrimido-(6,1-a)-isochinolin-4-on-derivaten und medizinische zubereitungen auf basis dieser verbindungen
JP2744853B2 (ja) * 1991-03-29 1998-04-28 品川白煉瓦株式会社 スライドバルブ装置用プレート煉瓦カートリッジ及び該カートリッジを用いたスライドバルブ装置
US6077822A (en) * 1993-09-14 2000-06-20 Dumex-Alpharma A/S Drug salts
CA2192481C (en) * 1994-06-10 2003-01-07 Hjarne Dyrsting Drug salts
AUPP310798A0 (en) * 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
DE102005060690B4 (de) * 2005-12-15 2008-09-25 Capsulution Nanoscience Ag Salze von Clopidogrel mit Polyanionen und ihre Verwendung zur Herstellung pharmazeutischer Formulierungen
JP5323324B2 (ja) * 2007-04-13 2013-10-23 大正製薬株式会社 ミノキシジル配合育毛剤の着色防止方法及びミノキシジル配合育毛剤が充填された容器
WO2012028496A1 (de) 2010-08-31 2012-03-08 Basf Se Verzweigte polyester auf basis von zitronensäure sowie deren herstellung und verwendung
EP3337459A1 (de) 2015-08-21 2018-06-27 Basf Se Salze von wirkstoffen mit polymeren gegenionen
JP6914916B2 (ja) 2015-08-21 2021-08-04 ビーエイエスエフ・ソシエタス・エウロパエアＢａｓｆ Ｓｅ Ｎ−ビニルピロリドン及びアクリル酸をベースとした水溶性ポリマーの医薬助剤としての使用
MX2018001546A (es) 2018-02-06 2019-08-07 Centro Int De Cosmiatria S A P I De C V Formulacion y metodo para el tratamiento de la alopecia androgenica.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE560809A (it) *
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
EP0093770B1 (en) * 1981-11-09 1991-06-19 BAZZANO, Gail S The use of retinoids and minoxidil (2,4-diamino-6-piperidino-pyrimidine-3-oxide) to increase the rate of growth of human scalp hair and to treat certain types of alopecias
NZ214397A (en) * 1984-12-21 1989-04-26 Richardson Vicks Inc Minoxidil and acrylate polymer topical compositions

Also Published As

Publication number Publication date
DE211268T1 (de) 1987-08-13
EP0211268A2 (en) 1987-02-25
IT8521654A0 (it) 1985-07-19
DE3681529D1 (de) 1991-10-24
ATE67488T1 (de) 1991-10-15
EP0211268A3 (en) 1988-01-20
EP0211268B1 (en) 1991-09-18
JPS6236367A (ja) 1987-02-17

Similar Documents

Publication Publication Date Title
IT1201436B (it) Formulazioni topiche a lento rilascio
NO930367D0 (no) Opasitetsmiddel for vannbaserte preparater
CA2091872A1 (en) Shampoo compositions and suspending agent therefor
DK0423714T3 (da) Hårrevitaliseringsmiddel
NO953967L (no) Indolderivater som 5-HT1A og/eller 5-HT2 ligander
IT1200589B (it) Derivati naturali attivita farmagologica
MY104772A (en) Dispersible granules of fungicidal products.
NO985094D0 (no) Polymerpulver som er redispergerbart i vandige l°sninger
ES2130131T3 (es) Composicion estabilizante de enzimas y su utilizacion en composiciones detergentes mejoradas que contienen enzimas estabilizadas.
RU92016277A (ru) Микробиоциды
NO930773D0 (no) Taxan-derivater, fremstilling derav, samt deres anvendelse som krefthindrende middel
DE59309648D1 (de) Mittel zum Reinigen und Konditionieren der Haare, der Haut sowie von Textilien und harten Oberflächen
EP0179430A3 (en) Aqueous pharmaceutical formulations of piroxicam monohydrate
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
ATE242220T1 (de) Benzimidazolderivate mit dopaminerger wirkung
DE69108402D1 (de) 5-fluor-2,4,6-pyrimidinthiaminderivate zur verhinderung des haarsausfalls.
ES2162807T3 (es) Composicion topica antibacteriana.
ZA91115B (en) Topical compositions
YU184090A (sh) Stabilizovani interferoni leukocita
EP0433663A3 (en) A permanent waving composition and a process for permanent waving of hair
GR3032031T3 (en) Cyclic amp derivative-containing ointment.
IT8721806A0 (it) Processo per la lotta contro lo sviluppo indesiderato delle piante e cosi' pure per la regolazione dello sviluppo della crescita delle piante.
TW225993B (en) A composition prevention hair loss and promoting hair growth and its usage
DK587285A (da) Azolholdige carbamoylerede oxamidsyreestere, deres fremstilling og andvendelse som plantebeskyttelsesmidler
ES2156765A1 (es) Composicion de un producto aplicable a la piel.